David J Clark - Net Worth and Insider Trading
David J Clark Net Worth
The estimated net worth of David J Clark is at least $98,687 dollars as of 2024-11-10. David J Clark is the Chief Medical Officer of Aldeyra Therapeutics Inc and owns about 17,878 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $98,687. Details can be seen in David J Clark's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David J Clark has not made any transactions after 2019-09-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David J Clark
David J Clark Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David J Clark owns 2 companies in total, including Aldeyra Therapeutics Inc (ALDX) , and Trevi Therapeutics Inc (TRVI) .
Click here to see the complete history of David J Clark’s form 4 insider trades.
Insider Ownership Summary of David J Clark
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-06 | Chief Medical Officer |
| TRVI | Trevi Therapeutics Inc | 2022-11-14 | Chief Medical Officer |
David J Clark Latest Holdings Summary
David J Clark currently owns a total of 1 stock. David J Clark owns 17,878 shares of Aldeyra Therapeutics Inc (ALDX) as of September 6, 2019, with a value of $98,687.
Latest Holdings of David J Clark
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-06 | 17,878 | 5.52 | 98,687 |
Holding Weightings of David J Clark
David J Clark Form 4 Trading Tracker
According to the SEC Form 4 filings, David J Clark has made a total of 0 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 5,000 shares on September 6, 2019, which cost David J Clark around $25,300.
Insider Trading History of David J Clark
- 1
David J Clark Trading Performance
GuruFocus tracks the stock performance after each of David J Clark's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J Clark is -4.06%. GuruFocus also compares David J Clark's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J Clark within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David J Clark's insider trading performs compared to the benchmark.
Performance of David J Clark
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.4 | | | | | |
| Relative Return to S&P 500(%) | 15.3 | | | | | |
David J Clark Ownership Network
Ownership Network List of David J Clark
Ownership Network Relation of David J Clark
David J Clark Owned Company Details
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
David J Clark is the Chief Medical Officer of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include Chief Development Officer Stephen Machatha , See Remarks Bruce Greenberg , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, David J Clark made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 57,346 shares made by Stephen Machatha , and a net sale of 37,236 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 26,875 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 26,875 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
David J Clark Mailing Address
Above is the net worth, insider trading, and ownership report for David J Clark. You might contact David J Clark via mailing address: 131 Hartwell Ave, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
